On a journey to diverse, inclusive, and more efficient rare disease trials
Impetus Digital
NOVEMBER 10, 2023
A version of this article was previously published on PharmaPhorum. As a result, many sponsors and investigators lack a thorough understanding of the condition in question and the lived patient experiences. Although orphan drugs represent a sizeable portion of new drug approvals , most rare diseases still lack effective treatment.
94 
Let's personalize your content